Pancreas and Islet Transplantation

Pancreas and Islet Transplantation represents a highly specialized field aimed at restoring endogenous insulin production in patients with type 1 diabetes and selected cases of severe pancreatic dysfunction. Featured at a global Surgery Conference, this session explores complex operative techniques, immunologic strategies, and evolving clinical protocols in pancreatic transplant surgery. With brittle diabetes and hypoglycemia unawareness significantly affecting patient quality of life, transplantation offers the potential for long-term glycemic stability and reduction of secondary complications.

Whole pancreas transplantation is often performed in conjunction with kidney transplantation in patients with diabetic nephropathy. The procedure involves vascular anastomosis to restore arterial inflow and venous drainage, along with enteric or bladder drainage of exocrine secretions. Careful recipient selection and donor organ preservation are critical to optimize graft function and minimize early thrombosis risk. Surgical precision during vascular reconstruction plays a decisive role in graft survival.

Islet transplantation provides a less invasive alternative, involving isolation of pancreatic islet cells and infusion into the recipient’s portal circulation. These cells engraft within the liver and begin insulin production, reducing or eliminating the need for exogenous insulin therapy. Although islet transplantation avoids major abdominal surgery, it requires meticulous cell preparation and immunosuppressive management to prevent rejection.

Postoperative management centers on immunomodulation protocols, metabolic monitoring, and infection prevention. Collaboration between transplant surgeons, endocrinologists, immunologists, and nephrologists ensures comprehensive long-term care. Advances in organ preservation techniques, including machine perfusion systems, have expanded donor eligibility and improved graft assessment.

Research in stem cell–derived islets, bioengineered pancreatic tissue, and immune tolerance induction continues to expand future possibilities. Encapsulation technologies aim to protect transplanted islet cells from immune attack while maintaining functionality. By integrating surgical innovation with metabolic science and transplant immunology, pancreas and islet transplantation remains a transformative therapeutic strategy for selected patients with complex endocrine disorders.